None
Conditions
Interventions
Intake of powdered lactic acid bacteria for 24 weeks
Intake of powdered placebo for 24 weeks
Sponsors
Morinaga Milk Industry Co., Ltd., Food Ingredients & Technology Institute, R&D Division
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Subjects of both sexes aged 20 years older and younger than 75 years.
Exclusion criteria
Exclusion criteria: 1) Subjects who have disease or serious medical history in liver, kidney, heart, lung, gastrointestinal tract, blood, endocrine system, or metabolism, etc. 2) Subjects who regularly use oral or nasal medications 3) Subjects with serious medication allergy, food allergy, or history of these 4) Subjects with severe perennial or seasonal allergic symptoms 5) Subjects who are scheduled to be vaccinated against COVID-19 from two weeks before the start of this study to the end of this study 6) Subjects who are pregnant, under lactation or expecting to be pregnant during this study 7) Subjects who participated in other study within 1 month prior to obtaining informed consent 8) Any candidates considered to be inappropriate for this study by the principal investigator based on their background, physical examination, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective symptoms of physical conditions | — |
Countries
Japan
Contacts
Public ContactShinji Nakamura
Yamaguchi Health Lab General manager
Outcome results
None listed